These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 1895548

  • 1. Thromboelastographic analysis of coagulation and fibrinolysis in rats with nephrotic syndrome induced by daunomycin.
    Shimizu K.
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):491-6. PubMed ID: 1895548
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography.
    Kupesiz A, Rajpurkar M, Warrier I, Hollon W, Tosun O, Lusher J, Chitlur M.
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):320-4. PubMed ID: 20400895
    [Abstract] [Full Text] [Related]

  • 4. [Chylomicron and VLDL metabolism in daunomycin-induced nephrotic rats].
    Gomikawa S, Hiraoka K, Yamanashi T, Mori H, Fujita Y, Takamitsu Y.
    Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):366-72. PubMed ID: 7637207
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Analysis of blood coagulation and fibrinolysis in rheumatoid arthritis using the urokinase activated thromboelastography].
    Motohashi Y, Nakazawa T, Kojima A.
    Ryumachi; 1992 Apr; 32(2):123-30. PubMed ID: 1595003
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Lipid metabolism in daunomycin induced nephrotic rats. (Part 4)].
    Gomikawa S, Takenaka Y, Nagasaka H, Shono T, Azuma M, Ihara H, Hirabayashi T, Yorifuji R, Inagaki O, Mori H.
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):999-1004. PubMed ID: 3244195
    [No Abstract] [Full Text] [Related]

  • 9. [Abnormal coagulation and fibrinolytic activities in glomerulonephritis and nephrotic syndrome].
    Nakagawa M, Nishio A.
    Nihon Rinsho; 1984 Jun; 42(6):1386-92. PubMed ID: 6482002
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blood coagulation, fibrinolysis and the mercurial nephrotic syndrome.
    Barr RD, Ouna N, Rees PH.
    J Trop Med Hyg; 1976 Oct; 79(10):235-6. PubMed ID: 1011317
    [No Abstract] [Full Text] [Related]

  • 13. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T, Muramatsu Y, Akashi S, Usui N.
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome.
    Thomson C, Forbes CD, Prentice CR, Kennedy AC.
    Q J Med; 1974 Jul; 43(171):399-407. PubMed ID: 4547474
    [No Abstract] [Full Text] [Related]

  • 18. Plasminogen activator in nephrotic syndrome.
    Andreenko GV, Podoroldskaya LV, Polyantseva LP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Jul; 115(3):351-5. PubMed ID: 2465229
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A model of daunorubicin-induced nephrotic syndrome in the rat].
    Jiang XY.
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):288-90. PubMed ID: 2804744
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.